CardioMET is an observational, multicenter, real-life registry, intending to collect data on patients with Type 2 Diabetes Mellitus, attending internal medicine and cardiology outpatient clinics. The aim of the registry is to characterize the cardiovascular risk profile and pharmacological management of Type 2 Diabetes Mellitus in Italy, in accordance with current ESC and AHA guidelines for primary and secondary prevention of CV disease.
Age ≥ 18 years;
Diagnosis of type 2 diabetes mellitus (T2DM);
Stable clinical conditions
Outpatient settings
Patients with type 1 diabetes mellitus;
Active participation in interventional studies;
Any condition that may put the patient at risk by participating in the study.